HCPCS Level II code J1700 denotes an injection of hydrocortisone acetate up to 25 mg, a corticosteroid used for anti-inflammatory and immunosuppressive treatment. This code matters nationally because injectable corticosteroids are commonly administered across outpatient clinics, physician offices, and ambulatory care settings; accurate coding affects claims processing, clinical documentation, and payer coverage determinations.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and service setting, common billing considerations, and what typical reimbursement and coverage discussions focus on for injectable corticosteroids. The publication summarizes benchmarks where available, highlights relevant policy updates affecting HCPCS Level II administration codes, and provides practical context for claims adjudication and documentation expectations.

The content is intended for a national audience and provides clarity on how J1700 is used in practice, what sites of service it most often appears in, and which payers typically handle claims for this injectable medication. Data not available in the input is noted where applicable.